Lumos Pharma, Inc. financial data

Symbol
LUMO on Nasdaq
Industry
Pharmaceutical Preparations
Location
4200 Marathon Blvd., Suite 200, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
NEWLINK GENETICS CORP (to 3/20/2020)
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 604 % -46.9%
Debt-to-equity 52.3 % +143%
Return On Assets -104 % -122%
Operating Margin -2.53K % -65.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.12M shares +2.38%
Common Stock, Shares, Outstanding 8.12M shares +1.02%
Entity Public Float 21.5M USD -53.7%
Weighted Average Number of Shares Outstanding, Basic 8.11M shares -0.64%
Weighted Average Number of Shares Outstanding, Diluted 8.11M shares -0.64%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 1.49M USD -33.3%
Revenue from Contract with Customer, Excluding Assessed Tax 1.49M USD -33.3%
Research and Development Expense 23.6M USD +21.6%
General and Administrative Expense 15.5M USD -8.16%
Operating Income (Loss) -37.6M USD -10.4%
Nonoperating Income (Expense) 1.87M USD -16.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.55M USD +15.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -35.7M USD -12.5%
Earnings Per Share, Basic -4.42 USD/shares -15.4%
Earnings Per Share, Diluted -4.42 USD/shares -15.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.8M USD -55.6%
Cash, Cash Equivalents, and Short-term Investments 36.1M USD -46.4%
Assets, Current 20.9M USD -62.7%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 463K USD +34.2%
Assets 21.4M USD -62.1%
Accounts Payable, Current 337K USD +20.8%
Employee-related Liabilities, Current 2.51M USD +2.83%
Accrued Liabilities, Current 4.29M USD -29.5%
Liabilities, Current 4.94M USD -24.6%
Operating Lease, Liability, Noncurrent 145K USD -13.2%
Liabilities 11.1M USD -12.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -180M USD -24.9%
Stockholders' Equity Attributable to Parent 10.3M USD -76.5%
Liabilities and Equity 21.4M USD -62.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.9M USD -40.2%
Net Cash Provided by (Used in) Financing Activities -5K USD +98.4%
Net Cash Provided by (Used in) Investing Activities 1M USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 8.15M shares +1.12%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.9M USD +0.59%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.8M USD -55.6%
Deferred Tax Assets, Valuation Allowance 133M USD +9.52%
Deferred Tax Assets, Gross 133M USD +9.52%
Operating Lease, Liability 585K USD +151%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -35.7M USD -12.4%
Lessee, Operating Lease, Liability, to be Paid 652K USD +176%
Operating Lease, Liability, Current 304K USD +69.8%
Lessee, Operating Lease, Liability, to be Paid, Year Two 303K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 332K USD +40.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +233%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 67K USD +2133%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17K USD
Deferred Tax Assets, Operating Loss Carryforwards 39M USD +10.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 190M USD +1.27%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2K USD -77.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 2.05M USD -15.3%
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%